PETSNasdaqRetail-Drug Stores and Proprietary StoresFiscal year ends March 31
PETMED EXPRESS INC
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.15−0.03 (-2.54%)
Close on Oct 19, 2026
- Market cap
- $24.93M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Petmed Express statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Retail-Drug Stores and Proprietary Stores companies for comparison
Valuation
| Measure | Petmed Express | Industry median |
|---|---|---|
| Market Cap | $24.93M | $123.11M |
| Enterprise Value | $11.85M | $132.88M |
| PS Ratio | 0.15 | 0.58 |
| PB Ratio | 1.08 | 1.75 |
| P/TBV Ratio | 1.41 | 2.92 |
Enterprise value
| Measure | Petmed Express | Industry median |
|---|---|---|
| EV / Sales | 0.07 | 0.61 |
Income (trailing twelve months)
| Measure | Petmed Express | Industry median |
|---|---|---|
| Revenue | $168.86M | $366.90M |
| Gross Profit | $47.15M | $250.49M |
| Operating Income | -$30.77M | -$275.87K |
| Pretax Income | -$29.35M | -$646.71K |
| Net Income | -$29.28M | -$948.56K |
| EBITDA | -$21.52M | $185.52K |
| EPS (Diluted) | -$1.38 | $0.00 |
Margins
| Measure | Petmed Express | Industry median |
|---|---|---|
| Gross Margin | 27.9% | 39.8% |
| Operating Margin | -18.2% | -0.44% |
| Pretax Margin | -17.4% | -0.66% |
| Profit Margin | -17.3% | -0.34% |
| EBITDA Margin | -12.7% | 1.22% |
| FCF Margin | -16.4% | 1.51% |
Returns
| Measure | Petmed Express | Industry median |
|---|---|---|
| Return on Equity (ROE) | -78.6% | -6.32% |
| Return on Assets (ROA) | -33.7% | -2.25% |
| Return on Invested Capital (ROIC) | -239.2% | -2.51% |
| Return on Capital Employed (ROCE) | -132.8% | 0.09% |
Growth
| Measure | Petmed Express | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -20.3% | 5.86% |
| Revenue Growth (3Y CAGR) | -10.2% | -1.38% |
| Revenue Growth (5Y CAGR) | -10.0% | 4.80% |
Balance sheet
| Measure | Petmed Express | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $13.08M | $22.34M |
| Net Cash (Debt) | $13.08M | $10.47K |
| Net Cash Per Share | $0.60 | $0.00 |
| Equity (Book Value) | $22.99M | $22.99M |
| Book Value Per Share | $1.06 | $0.92 |
| Tangible Book Value | $17.74M | $2.81M |
| Working Capital | -$12.99M | $3.42M |
Financial position
| Measure | Petmed Express | Industry median |
|---|---|---|
| Current Ratio | 0.68 | 1.15 |
| Quick Ratio | 0.36 | 0.44 |
Cash flow (trailing twelve months)
| Measure | Petmed Express | Industry median |
|---|---|---|
| Operating Cash Flow | -$23.81M | $1.90M |
| Capital Expenditures | -$3.96M | -$11.69M |
| Free Cash Flow | -$27.77M | $9.09M |
| FCF Per Share | -$1.28 | $0.30 |
Efficiency
| Measure | Petmed Express | Industry median |
|---|---|---|
| Asset Turnover | 1.95 | 1.46 |
| Inventory Turnover | 9.07 | 5.74 |
| Revenue Per Employee | $893.42K | $473.82K |
| Profits Per Employee | -$154.92K | -$6.50K |
| Employee Count | 189 | 361 |
Dividends and yields
| Measure | Petmed Express | Industry median |
|---|---|---|
| Earnings Yield | -117.4% | -2.14% |
| FCF Yield | -111.4% | 3.12% |
| Dividend Yield | 0.00% | 1.10% |
| Shareholder Yield | 0.00% | 0.67% |
| Dividend Per Share | $0.00 | $1.28 |
| Years of Dividend Growth | 0 | 0 |
Shares
| Measure | Petmed Express | Industry median |
|---|---|---|
| Shares Outstanding | 21,678,900 | 42,514,400 |
| Shares Change (YoY) | 3.50% | 1.64% |
| Shares Change (QoQ) | 1.39% | 0.27% |
| Float | 14,569,700 | 37,225,800 |
| Shares Held by Insiders | 32.8% | 7.90% |
| Shares Held by Institutions | 21.4% | 50.2% |
Taxes
| Measure | Petmed Express | Industry median |
|---|---|---|
| Income Tax | -$69.00K | $1.09M |
Scores
| Measure | Petmed Express | Industry median |
|---|---|---|
| Altman Z-Score | 1.25 | 1.50 |
| Piotroski F-Score | 2 | 5 |
Calculated by StockData from Petmed Express's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.